242 related articles for article (PubMed ID: 28467661)
21. Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men.
Similä ME; Kontto JP; Virtamo J; Hätönen KA; Valsta LM; Sundvall J; Männistö S
Br J Nutr; 2019 Apr; 121(8):938-944. PubMed ID: 30898176
[TBL] [Abstract][Full Text] [Related]
22. The effects of a high-fruit and -vegetable, high-fiber, low-fat dietary intervention on serum concentrations of insulin, glucose, IGF-I and IGFBP-3.
Flood A; Mai V; Pfeiffer R; Kahle L; Remaley AT; Rosen CJ; Lanza E; Schatzkin A
Eur J Clin Nutr; 2008 Feb; 62(2):186-96. PubMed ID: 17487212
[TBL] [Abstract][Full Text] [Related]
23. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
Jiang B; Liu DB; Zhang X; DU LL; Han CZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
[TBL] [Abstract][Full Text] [Related]
24. Effect of lycopene supplementation on insulin-like growth factor-1 and insulin-like growth factor binding protein-3: a double-blind, placebo-controlled trial.
Graydon R; Gilchrist SE; Young IS; Obermüller-Jevic U; Hasselwander O; Woodside JV
Eur J Clin Nutr; 2007 Oct; 61(10):1196-200. PubMed ID: 17299493
[TBL] [Abstract][Full Text] [Related]
25. Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia.
Yamaji T; Iwasaki M; Sasazuki S; Tsugane S
Int J Obes (Lond); 2012 Mar; 36(3):440-7. PubMed ID: 21673650
[TBL] [Abstract][Full Text] [Related]
26. Insulin-Like Growth Factor-I, Insulin-Like Growth factor Binding Protein-3 and Blood Hemoglobin Concentration in an Elderly Population.
Duron E; Vidal JS; Funalot B; Brunel N; Viollet C; Rigaud AS; Labourée F; Epelbaum J; le Bouc Y; Hanon O
J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):854-9. PubMed ID: 25384548
[TBL] [Abstract][Full Text] [Related]
27. The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition.
Crowe FL; Key TJ; Allen NE; Appleby PN; Roddam A; Overvad K; Grønbaek H; Tjønneland A; Halkjaer J; Dossus L; Boeing H; Kröger J; Trichopoulou A; Dilis V; Trichopoulos D; Boutron-Ruault MC; De Lauzon B; Clavel-Chapelon F; Palli D; Berrino F; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Vrieling A; van Gils CH; Peeters PH; Gram IT; Skeie G; Lund E; Rodríguez L; Jakszyn P; Molina-Montes E; Tormo MJ; Barricarte A; Larrañaga N; Khaw KT; Bingham S; Rinaldi S; Slimani N; Norat T; Gallo V; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1333-40. PubMed ID: 19423514
[TBL] [Abstract][Full Text] [Related]
28. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ
Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703
[TBL] [Abstract][Full Text] [Related]
30. Circulating insulin-like growth factor II and colorectal adenomas.
Renehan AG; Painter JE; O'Halloran D; Atkin WS; Potten CS; O'Dwyer ST; Shalet SM
J Clin Endocrinol Metab; 2000 Sep; 85(9):3402-8. PubMed ID: 10999841
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
33. [Study on the relations between serum insulin-like growth factor-1, insulin-like growth factor binding protein-3 and colorectal cancer: a meta-analysis].
Duan QH; Wang ZG; Zhu GB; Lu ZX; Shi LY; Nie SF
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Feb; 26(2):132-4. PubMed ID: 15921617
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-I and binding protein-3 and risk of cancer.
Giovannucci E
Horm Res; 1999; 51 Suppl 3():34-41. PubMed ID: 10592442
[TBL] [Abstract][Full Text] [Related]
35. Effects of calcium supplementation on biomarkers of inflammation and oxidative stress in colorectal adenoma patients: a randomized controlled trial.
Yang B; Gross MD; Fedirko V; McCullough ML; Bostick RM
Cancer Prev Res (Phila); 2015 Nov; 8(11):1069-75. PubMed ID: 26304464
[TBL] [Abstract][Full Text] [Related]
36. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai.
Probst-Hensch NM; Yuan JM; Stanczyk FZ; Gao YT; Ross RK; Yu MC
Br J Cancer; 2001 Nov; 85(11):1695-9. PubMed ID: 11742490
[TBL] [Abstract][Full Text] [Related]
37. Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction.
Iglesias P; Bayón C; Méndez J; Gancedo PG; Grande C; Diez JJ
Thyroid; 2001 Nov; 11(11):1043-8. PubMed ID: 11762714
[TBL] [Abstract][Full Text] [Related]
38. Associations of Current, Childhood, and Adolescent Milk Intake with Serum Insulin-like Growth Factor (IGF)-1 and IGF Binding Protein 3 Concentrations in Adulthood.
Srinivasan V; Nimptsch K; Rohrmann S
Nutr Cancer; 2019; 71(6):931-938. PubMed ID: 31045453
[TBL] [Abstract][Full Text] [Related]
39. Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.
Fuchs CS; Goldberg RM; Sargent DJ; Meyerhardt JA; Wolpin BM; Green EM; Pitot HC; Pollak M
Clin Cancer Res; 2008 Dec; 14(24):8263-9. PubMed ID: 19073970
[TBL] [Abstract][Full Text] [Related]
40. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
Renehan AG; Jones J; Potten CS; Shalet SM; O'Dwyer ST
Br J Cancer; 2000 Nov; 83(10):1344-50. PubMed ID: 11044360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
